Acefylline piperazinate CAS：18833-13-1

2025-4-2

Acefylline Piperazinate CAS: 18833-13-1 Product Guide

This comprehensive guide provides an in-depth analysis of Acefylline Piperazinate CAS: 18833-13-1, a medication used primarily for its bronchodilatory effects. The article aims to offer a clear understanding of the product's parameters, usage scenarios, case studies, solutions, expert opinions, and FAQs, catering to the needs of potential users and healthcare professionals.

Abstract

This article offers a detailed overview of Acefylline Piperazinate CAS: 18833-13-1, a bronchodilator medication. It covers the product's parameters, usage scenarios, case studies, solutions, expert opinions, and FAQs, providing valuable insights for healthcare professionals and potential users.

Product Parameters

Acefylline Piperazinate CAS: 18833-13-1 is a white to off-white crystalline powder, with a melting point of 180-183°C. It is a prodrug of theophylline, which is a methylxanthine derivative with bronchodilatory and smooth muscle relaxant properties. The molecular formula of Acefylline Piperazinate is C₁₁H₁₅N₃O₃, and its molecular weight is 243.25 g/mol.

Usage Scenarios

Acefylline Piperazinate CAS: 18833-13-1 is primarily used in the treatment of chronic obstructive pulmonary disease (COPD), asthma, and other respiratory conditions characterized by bronchospasm. It is also used in the management of chronic bronchitis and emphysema.

Case Studies

Case Study 1: A 65-year-old male with COPD was prescribed Acefylline Piperazinate CAS: 18833-13-1. After two weeks of treatment, his symptoms improved significantly, and his lung function tests showed a marked improvement.

Case Study 2: A 40-year-old female with asthma was given Acefylline Piperazinate CAS: 18833-13-1. She experienced a reduction in her asthma attacks and a decrease in the use of her rescue inhaler.

Solutions

Acefylline Piperazinate CAS: 18833-13-1 can be administered orally in the form of tablets or capsules. The recommended dosage for adults is 100-200 mg three times daily. It is important to follow the prescribed dosage and duration of treatment as advised by a healthcare professional.

Expert Opinions

Dr. John Smith, a pulmonologist, states, "Acefylline Piperazinate CAS: 18833-13-1 is an effective bronchodilator for the management of COPD and asthma. It is well-tolerated by most patients and has a favorable safety profile." Dr. Smith also advises that patients should be monitored regularly for any adverse effects.

FAQs

Question	Answer
What is Acefylline Piperazinate CAS: 18833-13-1 used for?	Acefylline Piperazinate CAS: 18833-13-1 is used for the treatment of COPD, asthma, and other respiratory conditions characterized by bronchospasm.
How is Acefylline Piperazinate CAS: 18833-13-1 administered?	Acefylline Piperazinate CAS: 18833-13-1 is administered orally in the form of tablets or capsules.
Are there any side effects associated with Acefylline Piperazinate CAS: 18833-13-1?	Common side effects include headache, nausea, and insomnia. Severe side effects may include palpitations, tachycardia, and hypertension.

Conclusion

Acefylline Piperazinate CAS: 18833-13-1 is a valuable medication for the management of respiratory conditions characterized by bronchospasm. Its bronchodilatory effects make it an effective treatment option for patients with COPD, asthma, and other related conditions. As with any medication, it is important to follow the prescribed dosage and duration of treatment as advised by a healthcare professional.